Kleresca launches new biophotonic treatment

October 10, 2018 0 By CH Unnikrishnan

Kleresca has released a new biophotonic technology for the treatment of rosacea.

The treatment uses fluorescent light energy to stimulate the skin’s own repair mechanisms through photobiomodulation.

The system consists of a patented, multi-LED Kleresca lamp designed with specific, pre-programmed wavelength settings and a specially formulated photoconverter gel. Chromophores in the gel convert light waves from the lamp into dynamic, pulsing fluorescent energy that stimulates the skin’s own repair mechanisms. The treatment is non-invasive and generally perceived as comfortable even to rosacea patients with enhanced skin sensitivity.

The treatment for rosacea is now available to patients through aesthetic clinics across 10 markets including Denmark, UK, France, Spain, Italy, Germany, Belgium, Norway, Australia and Switzerland.

Apart from reducing inflammation, the in-clinic treatment lowers the presence of papules and pustules; cuts down erythema and blushing by improving microvascularisation; mitigates the overall stress level of the skin, thereby reducing the feeling of burning and stinging and induces a healing response.

The Kleresca biophotonic system has been available on the market since 2014. The company recently obtained own CE-mark on all its products.